← Evidence map

ArticleCancer gene therapy2006

Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination.

J Steitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

this papercites it

Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination. | OpenQuestion